Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UY31262ApriorityCriticalpatent/UY31262A1/en
Publication of UY31262A1publicationCriticalpatent/UY31262A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invencién proporciona compuestos de formula (1). y la sal farmacéuticamente aceptable de los mismos, en el que R1, R2, R3, R4, R5a, R5b, R5c, R5d, Q, A, Z, y R7 son como se ha descrito en este documento; composiciones de los mismos; y usos de los mismos.The invention provides compounds of formula (1). and the pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5a, R5b, R5c, R5d, Q, A, Z, and R7 are as described herein; compositions thereof; and uses thereof.
DERIVATIVES OF THE 5- [4- (1,5-DIMETIL-1H-PIRAZOL-4-IL) -1,2,3-TRIAZOL-1-IL] -6-METHYL-NICOTINAMIDS N- (REPLACED) AND THE N- {5- [4- (1,5-DIMETHYL-1H-PIRAZOL-4-IL) -1,2,3-TRIAZOL-1-IL] -6-METHYL-PIRIDIN-3-IL} -BENZAMIDES REPLACED AND COMPOSITIONS CONTAINING THEM
DERIVATIVES OF (1 - {[5- (4-HALO-2-TRIFLUOROMETIL-PHENYLAMINE) PIRIDIN-2-ILMETIL] -CARBAMOIL -CICLOPROPIL) -PIRIMIDIN-CARBOXYLIC AND SIMILAR ACIDS; HIS ENANTIOMERS, HIS DIASTEREOISOMERS, AND HIS SALTS, PHYSIOLOGICALLY TOLERABLE.